Stocks · Korea
004720
KOSPI
PharmGen Science
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W-1.02%
1M-7.01%
3M-8.46%
6M-22.34%
1Y-36.38%
YTD-33.64%
52W high4,520원
52W low2,590원
From 52W high-35.40%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2021 | 1,099억 | -50억 | 324억 | -4.6% |
| 2022 | 1,509억 | 75억 | 701억 | 5.0% |
| 2023 | 1,668억 | 91억 | 57억 | 5.5% |
| 2024 | 1,713억 | 106억 | 28억 | 6.2% |
| Quarterly | ||||
| 2023 4Q | 465억 | 40억 | -3억 | 8.6% |
| 2024 1Q | 425억 | 30억 | 19억 | 7.1% |
| 2024 2Q | 429억 | 27억 | 10억 | 6.3% |
| 2024 3Q | 417억 | 31억 | -39억 | 7.3% |
| 2024 4Q | 442억 | 19억 | 37억 | 4.2% |
| 2025 1Q | 429억 | 20억 | -7억 | 4.8% |
Company
Address: 경기 화성시 향남면 상신리 향남제약공단 902-5
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
- 2026-05-15[기재정정]사업보고서 (2025.12)
- 2026-03-23사업보고서 (2025.12)
- 2025-11-14분기보고서 (2025.09)
- 2025-08-19[기재정정]반기보고서 (2025.06)
- 2025-08-14반기보고서 (2025.06)
- 2025-05-15분기보고서 (2025.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.